Treatment after failure: the problem of "non-responders".
about
Five-day proton pump inhibitor-based quadruple therapy regimen is more effective than 7-day triple therapy regimen for Helicobacter pylori infection.Risk factors for failure of Helicobacter pylori therapy--results of an individual data analysis of 2751 patients.The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysisEfficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infectionClarithromycin resistance and eradication of Helicobacter pylori in children.Are the orally administered proton pump inhibitors equivalent? A comparison of lansoprazole, omeprazole, pantoprazole, and rabeprazole.Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection.Review article: alternative antibacterial agents for Helicobacter pylori eradication.Second-line rescue therapy of helicobacter pylori infection.Molecular testing for antibiotic resistance in Helicobacter pylori.Review article: treatment of Helicobacter pylori infection and factors influencing eradication.Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.Antibiotic resistance of Helicobacter pylori strains in Japanese childrenDo patients with non-ulcer dyspepsia respond differently to Helicobacter pylori eradication treatments from those with peptic ulcer disease? A systematic review.Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori.Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in TurkeyTreatment and dosing of Helicobacter pylori infection: when pharmacology meets clinic.Helicobacter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimen."Rescue" regimens after Helicobacter pylori treatment failure.Review article: the global emergence of Helicobacter pylori antibiotic resistance.Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea.Acid suppression in healthy subjects following lansoprazole or pantoprazole.Helicobacter pylori Eradication Therapies in the Era of Increasing Antibiotic Resistance: A Paradigm Shift to Improved Efficacy.A pilot study to determine the effectiveness of garlic oil capsules in the treatment of dyspeptic patients with Helicobacter pylori.Sequential Therapy for Helicobacter Pylori Eradication: The Time is Now!A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study.Third-line rescue therapy for Helicobacter pylori infection.Causes of failure of eradication of Helicobacter pylori.Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy?High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study.Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication.Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies.A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection.Efficacy of two levofloxacin-containing second-line therapies for Helicobacter pylori: a pilot study.Effectiveness and safety of repeated quadruple therapy in Helicobacter pylori infection after failure of second-line quadruple therapy: repeated quadruple therapy as a third-line therapy.Resistance mechanisms of Helicobacter pylori and its dual target precise therapy.Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea.Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial.
P2860
Q32026771-468DDCA8-6F78-411A-A547-EF5E5C0EBA18Q33185503-5C7A9EF1-FFDF-4861-91F3-9CCB8F60667AQ33287535-2AB3CCC9-1381-451D-B33B-123A6F094F55Q33291670-4D09811F-9C0A-4698-8556-4AFCFAE5341DQ33982581-06C37F84-B68A-4656-8068-CE4042F84F3BQ34082750-C8EAB63D-1EDC-4B9B-8CFF-F05434BF98B2Q34291666-5C98FE05-D9D9-4BCE-B7E5-776F2625A035Q34374147-3856E198-471B-4BE9-AFDE-7A83A952A5AAQ34409114-3A9A3DE9-B922-4387-96F5-68A8B7632D47Q34526014-6A824E0B-F405-4409-B98A-A87AA75942AAQ34534317-06961457-FD9B-420A-85E6-CAC403FC4D86Q34657352-9D02EB77-CE80-4438-8BA4-DBADE3FDCA49Q34946883-0BF86BB0-5D88-49A1-AB0C-661188783254Q35011223-96BF0E13-0AFB-4CB1-95E9-B8EEFEB72F8BQ36067522-EF8FE57E-8B25-48C4-BF72-650210967A5EQ36474120-5AC25019-4EE7-4C94-BB87-BBB9CEFEC9EAQ36723844-DA2BCEC9-7F05-477F-BF00-3FA147F40D4BQ36883328-BFBFC1A7-FBE4-4CC5-A91B-FC026BCD2CBDQ37273653-50C665CF-5920-4CD8-B1FD-33C806CC7549Q37340339-39C32B5C-164C-4B65-BDFD-51A3F58D93F7Q37624449-242C1744-DEA1-4000-AD39-A97B7DA8A4B2Q39409890-101B7B01-B6B7-4322-A5C5-5A6788848FF9Q39588933-ED390C3E-FF3F-412C-A8F7-B5F9F2D49A53Q40679020-87C0205F-49CD-4AB7-852E-16334E238351Q41173895-D4F9FFC5-D7FE-4733-BC59-9369C910AE26Q41391795-74F30D6E-F465-4C1F-9DAF-DAB3D7313A50Q42726333-8F43CC12-C4C5-4E4E-B027-F372B7B1962DQ42778635-2B906942-ACA7-468B-9913-F16409340975Q43650361-804FC5C1-D790-46CF-8780-00FEAB3599F0Q43892527-59AD2A1A-A122-43BC-9A2F-EA3ADFEDEB1EQ43904283-9634844C-DBC5-4E16-974C-ADBAB2FA65E1Q43904297-F9C4A4D6-0F7C-4BE3-B7AE-35714A6F5F79Q44570126-CEE8BD5C-A839-45BE-9FC7-B6B768940E31Q44813868-48A5C105-3B4E-48D5-8F0C-3EF6E1EEE425Q46049471-31745C00-05A6-4896-BA31-A79E1976EED6Q51008107-FE0A66DA-1652-44E5-BEB4-55079EDF22EAQ52732728-24CE2D05-7A13-40E8-A1BE-EAE4F0863F76Q53406185-79FA9A6D-A236-4FA7-8971-A81B3D8A8ED0Q54592157-7735D660-1D3A-47AE-8C3A-57203DB9C37EQ55280909-F7BFE30A-DDCD-4631-BA7A-0998C27F4BC2
P2860
Treatment after failure: the problem of "non-responders".
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Treatment after failure: the problem of "non-responders".
@ast
Treatment after failure: the problem of "non-responders".
@en
type
label
Treatment after failure: the problem of "non-responders".
@ast
Treatment after failure: the problem of "non-responders".
@en
prefLabel
Treatment after failure: the problem of "non-responders".
@ast
Treatment after failure: the problem of "non-responders".
@en
P2860
P356
P1433
P1476
Treatment after failure: the problem of "non-responders".
@en
P2093
P2860
P356
10.1136/GUT.45.2008.I40
P407
P478
45 Suppl 1
P577
1999-07-01T00:00:00Z